A microcosting study of microsurgery, LINAC radiosurgery, and gamma knife radiosurgery in meningioma patients

Siok Swan Tan, E van der Putten, Wideke Nijdam, P Hanssens, GN Beute, Peter Nowak, Clemens Dirven, Leona Hakkaart - van Roijen

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
3 Downloads (Pure)

Abstract

The aim of the present study is to determine and compare initial treatment costs of microsurgery, linear accelerator (LINAC) radiosurgery, and gamma knife radiosurgery in meningioma patients. Additionally, the follow-up costs in the first year after initial treatment were assessed. Cost analyses were performed at two neurosurgical departments in The Netherlands from the healthcare providers' perspective. A total of 59 patients were included, of whom 18 underwent microsurgery, 15 underwent LINAC radiosurgery, and 26 underwent gamma knife radiosurgery. A standardized microcosting methodology was employed to ensure that the identified cost differences would reflect only actual cost differences. Initial treatment costs, using equipment costs per fraction, were a,not sign12,288 for microsurgery, a,not sign1,547 for LINAC radiosurgery, and a,not sign2,412 for gamma knife radiosurgery. Higher initial treatment costs for microsurgery were predominantly due to inpatient stay (a,not sign5,321) and indirect costs (a,not sign4,350). LINAC and gamma knife radiosurgery were equally expensive when equipment was valued per treatment (a,not sign2,198 and a,not sign2,412, respectively). Follow-up costs were slightly, but not significantly, higher for microsurgery compared with LINAC and gamma knife radiosurgery. Even though initial treatment costs were over five times higher for microsurgery compared with both radiosurgical treatments, our study gives indications that the relative cost difference may decrease when follow-up costs occurring during the first year after initial treatment are incorporated. This reinforces the need to consider follow-up costs after initial treatment when examining the relative costs of alternative treatments.
Original languageUndefined/Unknown
Pages (from-to)237-245
Number of pages9
JournalJournal of Neuro-Oncology
Volume101
Issue number2
DOIs
Publication statusPublished - 2011

Cite this